| A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants RTS,S Clinical Trials Partnership, Agnandji ST The New England Journal of Medicine, 2012 | 2221* | 2012 |
| Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites RTS, S Clinical Trials Partnership (2014) PLoS medicine 11 (7), e1001685, 2014 | 344 | 2014 |
| Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based … Z Zhou, RM Mitchell, S Kariuki, C Odero, P Otieno, K Otieno, P Onyona, ... Malaria journal 15, 1-13, 2016 | 69 | 2016 |
| Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994–2009 J Wong, MJ Hamel, CJ Drakeley, S Kariuki, YP Shi, AA Lal, BL Nahlen, ... Malaria journal 13, 1-14, 2014 | 60 | 2014 |
| A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya A Agarwal, M McMorrow, P Onyango, K Otieno, C Odero, J Williamson, ... Malaria journal 12, 1-8, 2013 | 56 | 2013 |
| Safety and immunogenicity of RTS, S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial L Otieno, M Oneko, W Otieno, J Abuodha, E Owino, C Odero, ... The Lancet Infectious Diseases 16 (10), 1134-1144, 2016 | 36 | 2016 |
| In‐vivo efficacy of amodiaquine‐artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya JI Thwing, CO Odero, FO Odhiambo, KO Otieno, S Kariuki, R Ord, ... Tropical medicine & international health 14 (3), 294-300, 2009 | 36 | 2009 |
| Genetic diversity of Plasmodium falciparum parasite by microsatellite markers after scale-up of insecticide-treated bed nets in western Kenya W Gatei, JE Gimnig, W Hawley, F Ter Kuile, C Odero, NC Iriemenam, ... Malaria Journal 14, 1-12, 2015 | 32 | 2015 |
| Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya M Shah, Y Omosun, A Lal, C Odero, W Gatei, K Otieno, JE Gimnig, F Kuile, ... Malaria journal 14, 1-14, 2015 | 27 | 2015 |
| Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections AM Early, M Lievens, BL MacInnis, CF Ockenhouse, SK Volkman, S Adjei, ... Nature communications 9 (1), 1381, 2018 | 24 | 2018 |
| Modelling the relationship between malaria prevalence as a measure of transmission and mortality across age groups S Khagayi, M Desai, N Amek, V Were, ED Onyango, C Odero, K Otieno, ... Malaria journal 18, 1-12, 2019 | 18 | 2019 |
| Costs of continuing RTS, S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries R Baral, A Levin, C Odero, C Pecenka, C Tabu, E Mwendo, G Bonsu, ... PLoS One 16 (1), e0244995, 2021 | 17 | 2021 |
| National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study J Price, J Mooney, C Bain, JT Bawa, N Gurley, A Kumar, G Liyanage, ... Vaccine 40 (2), 370-379, 2022 | 8 | 2022 |
| Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: development of study site infrastructure and … NA Odero, AM Samuels, W Odongo, B Abong’o, J Gimnig, K Otieno, ... Malaria Journal 18, 1-12, 2019 | 8 | 2019 |
| Factors Influencing Strategy Implementation on the Performance of Commercial Banks in Kenya: A Case of Co-Operative Bank of Kenya G Rotich, CO Odero The Strategic Journal of Business and Change Management 3 (3), 4, 2016 | 8 | 2016 |
| Cost of introducing and delivering RTS, S/AS01 malaria vaccine within the malaria vaccine implementation program R Baral, A Levin, C Odero, C Pecenka, JT Bawa, KO Antwi-Agyei, ... Vaccine 41 (8), 1496-1502, 2023 | 6 | 2023 |
| Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low-and middle-income settings JA Fleming, N Gurley, S Knudson, L Kabore, JT Bawa, P Dapaah, ... Vaccine: X 15, 100368, 2023 | 3 | 2023 |
| Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries J Mooney, J Price, C Bain, JT Bawa, N Gurley, A Kumar, G Liyanage, ... Plos one 17 (6), e0270369, 2022 | 3 | 2022 |
| Trends of non-vaccination, under-vaccination and missed opportunities for vaccination (2003–2014) amongst children 0–23 months in Kenya CO Odero, D Othero, VO Were, C Ouma PLOS Global Public Health 4 (2), e0002906, 2024 | | 2024 |
| Correction: Costs of continuing RTS, S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries R Baral, A Levin, C Odero, C Pecenka, C Tabu, E Mwendo, G Bonsu, ... Plos one 16 (4), e0250863, 2021 | | 2021 |
Simon KariukiKenya Medical Research InstituteVerified email at kemricdc.org
